Center for Breakthrough Medicines is partnering with Discovery Labs to speed up its plans to build the capacity to manufacture a substantial number of cell…

University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process…

The Center for Breakthrough Medicines, which is based within MLP Ventures’ Discovery Labs innovation hub campus in King of Prussia, has secured an equity investment…

Life Sciences PA (LSPA) has announced they are moving its headquarters from its current location on Swedesford Rd. in Wayne to 411 Swedeland Road in…

Out of the 76 main power players in Philadelphia who made moves in the last year and also have a huge role in determining our…

King of Prussia has seen an astonishing development boom in the last decade, which has solidified its place as the center of Philadelphia’s western…

The former GlaxoSmithKline property in King of Prussia has added University of Pennsylvania’s gene therapy program as a new tenant, writes Jacob Adelman for…

In a real estate deal worth roughly $100 million, MLP Ventures has bought its partners out of their interest in the Discovery Labs in King…

Despite the pandemic, development of the Center for Breakthrough Medicines in King of Prussia’s Discovery Labs innovation hub is still on track to be…

With traditional office tenants looking for ways to cut back on square footage amid the pandemic, life science companies have emerged as a bright spot…

Local commercial real estate markets are thriving as a number of Philadelphia start-ups search out more affordable space in the suburbs due to the…

Joerg Ahlgrimm, a former Baxter Healthcare executive, has joined King of Prussia based Discovery Labs as its president and chief operating officer, writes John George…

Audrey Greenberg, co-founder and executive managing director of Discovery Labs in King of Prussia, is one of the trailblazing women in Philadelphia’s healthcare…

The rapidly-growing biotech company WuXi Biologics has leased space at the Discovery Labs in King of Prussia and is planning to add 100 new…

Brian O’Neill, the King of Prussia real estate mogul known for his outrageous ambition, has decided to step into the cell and gene therapy…

Main Line developer Brian O’Neill is planning to build a $1.1 billion cell and gene therapy manufacturing facility as part of the Discovery…